Compound ID | 337
Class: Beta-lactam
| Agent Type: | Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against vancomycin-resistant Enterococcus and methicillin-resistant Staphylococcus aureus |
| Institute where first reported: | Procter and Gamble Pharmaceuticals, Ireland |
| Year first mentioned: | 2000 |
| Development status: | Experimental |
| External links: |